top of page
Contract Manufacturing
Agile and Responsive Contract Manufacturing Solutions
Our CMO services offer scalable and quality-driven manufacturing of oral solid dose and softgel pharmaceutical products. Our advanced facilities and experienced teams ensure consistent product quality, safety, and regulatory compliance.
High-Potency Manufacturing Capabilities
Our state-of-the-art manufacturing suites are equipped to handle high-potency finished products across multiple dosage formats, ensuring flexibility, safety, and compliance at every stage.
Film-Coated Tablets
Softgel Capsules
Liquid/Powder
Hard-Shell Capsules
End-To-End Oral Solid Dose Manufacturing
Drug Dosage Forms
-
Multiple Active Formulations
​
-
High Potency APIs
​
-
Mini/Micro Tablets
​
-
Capsules & Over-Encapsulation
​
-
Liquids, Pellets, Granules
Manufacturing Process
-
Wet & Dry Granulation
​
-
Spray Coating
​
-
Direct Compression (Dry Blend)
​
-
Soft Gel Encapsulation
​
-
Liquid-Fill Hard Capsules
​
-
Clinical Printing
Drug Packaging Types
​​
-
Blister & Bottle
​
-
Tamper-Evident, Induction-Sealed
​
-
Clinical Kit Packaging
​
-
Sachets
​
-
2D Matrix Unit Serialization
We understand the need for flexibility in today's pharmaceutical landscape. We adapt to your molecule, your needs, and your vision. Our high containment manufacturing and packaging capabilities are built to scale with complexity, ensuring safe, efficient production of even the most potent compounds.
Multi-Product Capability
Our high containment suites are equipped to manage diverse, high-potency molecules across multiple projects simultaneously.
Science-Driven Development
From early formulation through to commercial scale-up, our R&D and technical teams work alongside you, tailoring processes to your specifications.
Flexible Containment Solutions
Closed-loop isolators and powder containment systems for GMP manufacturing enable precision and safely - on your terms.
Secure Packaging for Global Markets
Whether clinical trials or commercial launch, our packaging facility scales with your supply chain demands.
Coming Soon!
Our Additional 500 Million Unit Expansion
In late 2025, we're launching our cutting-edge manufacturing facility, expanding our capacity for high-potency development and commercial supply. By 2027, we aim to have our annual output capacity 1 billion units. This new facility enhances our ability to support your journey from molecule to market - with agility and scientific depth.
bottom of page